Tag: Paxlovid

Feds Bet on Wrong COVID Horse Again as Pfizer’s Own Research Casts Doubt on Pricey Paxlovid

Just the News
Pfizer Research and Development lab La Jolla, CA

There may be a reason Pfizer chose that curious tagline in the drugmaker’s once-inescapable commercials for its COVID-19 oral antiviral – the subject of a “Saturday Night Live” parody – which cost U.S. taxpayers at least $12 billion before the feds tightened the spigot last fall and Pfizer jacked the price to $1,390 for a five-day course.

The nirmatrelvir-ritonavir combination marketed as Paxlovid does no better against so-called long COVID than a placebo taken with ritonavir, according to a new “original investigation” quietly released Friday in JAMA Internal Medicine, published by the Journal of the American Medical Association.

Read the full story

‘Unacceptable Incompetence’: CDC Made Dozens of Basic Data Errors on COVID, Epidemiologists Find

Just the News
Sick person talking to CDC employee

The Center for Disease Control and Prevention (CDC) found itself hoist with its own petard by making 25 basic statistical and numerical errors related to COVID-19, particularly with regard to children, while purporting to expose COVID vaccine misinformation, according to an analysis led by University of California San Francisco epidemiologists.

The preprint, which has not yet been peer-reviewed, documented 20 errors that “exaggerated the severity of the COVID-19 situation” and three that “simultaneously exaggerated and downplayed” severity, while one each was neutral or exaggerated vaccine risks.

Read the full story

President Biden Tests Positive for COVID-19 Again

Admin

President Biden on Saturday tested positive for COVID-19 again, the White House state in a statement.

A statement was from the White House physician and said the 79-year-old president tested positive “late Saturday morning” after multiple negative tests earlier in the week. He returned to in-person work Wednesday, after having tested positive days earlier. The situation of getting COVID soon after having already contracted the virus is frequently referred to as “rebound” COVID.

Read the full story

Oral Antiviral Therapeutics to Combat COVID-19 More Available in Tennessee

Kaitlin Housler
pharmacy

The two oral antiviral therapeutics developed by pharmaceutical companies Merck and Pfizer to treat mild to moderate cases of COVID-19 are readily available to patients in Tennessee as a part of an increased bi-weekly allocation program.

“This increase in allocations is something we have been anticipating for weeks,” Tennessee Department of Health Commissioner Dr. Lisa Piercey, MD, MBA, FAAP said in a statement. “Our goal has always been to increase access to these treatments by onboarding more pharmacies to maximize access to patients. We have seen a steady increase in allocations to the state and know many pharmacies and providers are eager to offer this treatment to help mitigate COVID-19 disease progression for those at risk of a severe outcome.”

Read the full story